4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359678
Co-Chief Executive Officer acquired 60,039 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Klee Justin B. · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-18 | Grant or award : show line 1 in the form | +60,039 | 3,643,520 | D |
Loading xslF345X06/ownership.xml…